[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651231":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":53,"collaborators":55,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":22,"eligibilityCriteria":64,"healthyVolunteers":61,"sex":65,"minAge":66,"maxAge":22,"enrollmentInfo":67,"targetDuration":22,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":22,"overallStatus":78,"whyStopped":22,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Sanford Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MMA Embolization","EXPERIMENTAL","Participants will be sequentially assigned one of three MMAE treatment strategies (particles, liquid embolics, or coils) in the order they become eligible and agree to participate. Radiographic and clinical outcomes will be compared.",[13,14,15],"Device: Particles (polyvinyl alcohol or similar microspheres)","Device: Liquid Embolics (Onyx, n-BCA, or equivalent)","Device: Phenox Coils (Avenir UNO Helical Coil)",[17,23,26],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":22},"DEVICE","Particles (polyvinyl alcohol or similar microspheres)","Participants will be sequentially enrolled into one of three clinically accepted MMAE treatment strategies (interventions) to compare radiographic and clinical outcomes.",[9],null,{"type":18,"name":24,"description":20,"armGroupLabels":25,"otherNames":22},"Liquid Embolics (Onyx, n-BCA, or equivalent)",[9],{"type":18,"name":27,"description":20,"armGroupLabels":28,"otherNames":22},"Phenox Coils (Avenir UNO Helical Coil)",[9],[30],{"name":31,"affiliation":5,"role":32},"Divyajot Sandhu, MD, MBBS","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":22,"email":38},"Alycia Abler Clinical Research Project Manager","CONTACT","(701) 417-2002","alycia.abler@sanfordhealth.org",[40],{"facility":41,"status":22,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":22},"Sanford USD Medical Center","Sioux Falls","South Dakota","57105","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-96.72796,43.54369,{"lat":51,"lon":50},{"type":54,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR",[56],{"name":57,"class":58},"phenox Inc.","INDUSTRY","100651231","comparative-study-of-embolic-agents-in-patients-with-subdural-hemorrhage-undergoing-middle-meningeal-artery-mma-embolization-100651231",false,"NCT07757113","Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization","Inclusion Criteria:\n\n* Adult patients (≥ 18 years)\n* Undergoing Middle Meningeal Artery Embolization (MMAE) for chronic subdural hematoma (cSDH)\n* Able to provide informed consent or have a legally authorized representative (LAR) do so\n\nExclusion Criteria:\n\n* Ineligible for MMAE procedure, as deemed by the treating physician, for any indication (e.g. pregnancy)\n* Non-chronic subdural hematoma (cSDH) indications for Middle Meningeal Artery Embolization (MMAE), including acute subdural hematoma with symptom onset \\\u003C 72 hours or mixed acute\u002Fchronic without predominant chronic features\n* Pregnancy or breastfeeding\n* Known severe allergy or contraindication to embolic materials (e.g. particles, liquids like Onyx\u002Fn-BCA, or coils)\n* Inability to undergo angiography (e.g. severe renal impairment contraindicating contrast)\n* Inability or unwillingness to complete follow-up visits at 30 and 90 days","ALL","18 Years",{"count":68,"type":69},30,"ESTIMATED","INTERVENTIONAL",[72],"NA","Single site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.",[75,76,77],"Chronic Subdural Hematoma","Stroke","Middle Meningeal Artery Embolization","NOT_YET_RECRUITING","2026-08-05",{"date":81,"type":82},"2026-08-11","ACTUAL",{"date":84,"type":69},"2026-09",{"date":86,"type":69},"2028-03",{"name":5,"class":6},1]